1. High Cost Per Lead
Due to limited targeting options and low audience relevance, Facebook’s cost per lead (CPL) for medical campaigns—especially in restricted categories like stem cell therapy—is often two to three times higher than average. Clinics spend thousands just to get a handful of inquiries, many of which never convert.
2. Low Intent Leads
The majority of Facebook users are scrolling for entertainment, not actively searching for treatment options. This means that most leads generated from Facebook ads are “curious clickers” who aren’t ready—or able—to move forward with care.
3. High Rate of Spam and Fraud Clicks
Social media ads attract a lot of junk traffic. Many clinics report getting flooded with fake names, bots, and overseas accounts that waste budget and distort performance metrics. Without proper fraud protection, ad spend can vanish with little to show for it.
4. Strict Compliance Restrictions
Facebook (now Meta) has tight restrictions on advertising anything related to “experimental or unapproved medical treatments.” Ads that mention stem cells, regenerative medicine, or similar keywords are often disapproved or limited in reach—even if your content is educational and compliant.
5. Unreliable Audience Targeting
Over the past few years, Facebook has removed or restricted most detailed targeting options related to health conditions, symptoms, or medical interests. As a result, it’s now much harder to reach people who are genuinely seeking treatment.
6. Short Attention Spans & Poor Lead Quality
Even when ads generate leads, follow-up quality is often low. Many social users don’t answer calls, respond to texts, or show up for consultations—leading to wasted time and energy for your front desk team.
7. Constant Algorithm Changes
Facebook’s advertising algorithm is unpredictable. A campaign that performs well one month can completely crash the next due to platform updates or policy shifts—making it difficult to maintain consistent ROI.

